Literature DB >> 16413919

IL-1 can act as number one.

Ana M Gamero1, Joost J Oppenheim.   

Abstract

Both interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) signal via the adapter molecule MyD88. However, in response to a cutaneous infection challenge, the downstream signaling events diverge and IL-1R, but not TLR2, proves to be essential for host defense.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16413919     DOI： 10.1016/j.immuni.2005.12.007

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  8 in total

1.  Murine cerebral malaria development is independent of toll-like receptor signaling.

Authors:  Dieudonnée Togbe; Louis Schofield; Georges E Grau; Bruno Schnyder; Victorine Boissay; Sabine Charron; Stéphanie Rose; Bruce Beutler; Valérie F J Quesniaux; Bernhard Ryffel
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 2.  Microarray-based identification of novel biomarkers in IL-1-mediated diseases.

Authors:  Florence Allantaz; Damien Chaussabel; Jacques Banchereau; Virginia Pascual
Journal:  Curr Opin Immunol       Date:  2007-11-26       Impact factor: 7.486

Review 3.  Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury.

Authors:  Dieudonnée Togbe; Silvia Schnyder-Candrian; Bruno Schnyder; Emilie Doz; Nicolas Noulin; Laure Janot; Thomas Secher; Pamela Gasse; Carla Lima; Fernando Rodrigues Coelho; Virginie Vasseur; François Erard; Bernhard Ryffel; Isabelle Couillin; Rene Moser
Journal:  Int J Exp Pathol       Date:  2007-12       Impact factor: 1.925

Review 4.  How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Authors:  Virginia Pascual; Florence Allantaz; Pinakeen Patel; A Karolina Palucka; Damien Chaussabel; Jacques Banchereau
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

5.  Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.

Authors:  Philip T Liu; Mirjam Schenk; Valencia P Walker; Paul W Dempsey; Melissa Kanchanapoomi; Matthew Wheelwright; Aria Vazirnia; Xiaoran Zhang; Andreas Steinmeyer; Ulrich Zügel; Bruce W Hollis; Genhong Cheng; Robert L Modlin
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

6.  The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

Authors:  Joppe W R Hovius; Maarten F Bijlsma; Gerritje J W van der Windt; W Joost Wiersinga; Bastiaan J D Boukens; Jeroen Coumou; Anneke Oei; Regina de Beer; Alex F de Vos; Cornelis van 't Veer; Alje P van Dam; Penghua Wang; Erol Fikrig; Marcel M Levi; Joris J T H Roelofs; Tom van der Poll
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

7.  Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.

Authors:  Florence Allantaz; Damien Chaussabel; Dorothee Stichweh; Lynda Bennett; Windy Allman; Asuncion Mejias; Monica Ardura; Wendy Chung; Elisabeth Smith; Carol Wise; Karolina Palucka; Octavio Ramilo; Marilynn Punaro; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

8.  Essential role of interleukin-1 signaling in host defenses against group B streptococcus.

Authors:  Carmelo Biondo; Giuseppe Mancuso; Angelina Midiri; Giacomo Signorino; Maria Domina; Veronica Lanza Cariccio; Mario Venza; Isabella Venza; Giuseppe Teti; Concetta Beninati
Journal:  mBio       Date:  2014-09-09       Impact factor: 7.867
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.